Syndax Pharmaceuticals is looking for a Director, Biostatistics
At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax Pharmaceuticals is a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies.
The Role:
This role provides expertise and guidance in collaboration with cross-functional groups broadly across the organization in establishing study design and analyses in addition to strategy, and institutes best practices with regards to planning, execution, interpretation and regulatory submission of clinical projects and studies. This role also provides oversight and guidance to ensure high quality and timely deliverables. This person will have strong technical expertise, will be a collaborative team player and proactive problem solver.
Key Responsibilities:
- Provide strategic input to optimize trial designs in both early phase and/or late phase registrational studies
- Proactively collaborate with clinical trial team to support study conduct
- Provide oversight into external CRO to ensure timely deliverables
- Serve as statistical lead in support of IND/NDA/MAA or other regulatory interactions; provide thorough reviews for clinical documents, briefing books, and required components of regulatory submissions including appropriate datasets, define files, reviewer's guides, and other relevant documents
- Perform QC of statistical deliverables including validation of key results
- Author or oversee the development of statistical analysis plans, statistical sections of protocols, and clinical study reports
- Collaborate closely with the Medical Affairs and other departments to support evidence generation and publication
- Stay updated with regulatory requirements and advanced statistical methodology
- Conduct ad hoc analyses if needed.
- Lead initiatives within Biostatistics function, and contribute to cross-functional process improvement efforts
- Additional duties and responsibilities as required
Desired Experience/Education and Personal Attributes:
- Ph.D. or M.S., Biostatistics or equivalent with at least 5 years of pharmaceutical, biotechnology, or equivalent experience.
- Profound understanding of advanced clinical trial design and statistical analysis methodologies
- Good understanding of the big picture of an overall development program
- Capable of thinking strategically
- Excellent communication and interpersonal skills
- Ability to lead project teams, as well as work in a cross-functional team
- Good leadership skills
- Strong ability to quickly capture key information from medical journal articles
- Understand regulatory requirements and good clinical practice guidelines
- Ability to multitask and prioritize work
- Good statistical programming skills using SAS and other statistical software
Location: Syndax’s corporate office is in New York, NY.
Syndax offers a total compensation and rewards package that is among the most competitive in the industry. Base pay is just one element of our package and is determined within a range based on several factors including market data, experience, qualifications, demonstrated skills, relevant education or training, travel requirements and internal equity. Our overall package also includes an equity offering, annual target bonuses, and an outstanding benefits program. The anticipated annualized salary range for this role is $235,000 -$260,000.
About Syndax:
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com/ or follow the Company on X and LinkedIn.
Syndax Pharmaceuticals is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.
#LI- Remote
Skills Required
- Ph.D. or M.S. in Biostatistics or equivalent
- At least 5 years of pharmaceutical, biotechnology, or equivalent experience
- Profound understanding of advanced clinical trial design and statistical analysis methodologies
- Understanding of the overall development program and ability to think strategically
- Excellent communication and interpersonal skills
- Ability to lead project teams and work cross-functionally
- Strong leadership skills
- Ability to quickly capture key information from medical journal articles
- Understanding of regulatory requirements and good clinical practice guidelines
- Ability to multitask and prioritize work
- Strong statistical programming skills using SAS and other statistical software
Syndax Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Syndax Pharmaceuticals and has not been reviewed or approved by Syndax Pharmaceuticals.
-
Healthcare Strength — Health coverage is described as excellent, spanning medical, dental, and vision with added wellness reimbursement. Employer-funded medical and an HSA option further reinforce perceived quality and value.
-
Retirement Support — The 401(k) program is portrayed as notably strong, with employer matching highlighted as a standout feature. Company disclosures position retirement support as a competitive advantage.
-
Equity Value & Accessibility — Equity participation is common, with frequent new‑hire inducement stock option grants and annual bonuses as part of total rewards. Typical four‑year vesting schedules help translate equity into longer‑term value.
Syndax Pharmaceuticals Insights
What We Do
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. Review our social media community guidelines below: https://syndax.com/social-media-community-guidelines/









